18713 studies found for:    updated in the last 60 days
Show Display Options
Rank Status Study
1 Recruiting Human Epilepsy Genetics--Neuronal Migration Disorders Study
Conditions: Epilepsy;   Seizures;   Cognition Disorders;   Neuronal Migration Disorders
Intervention:
2 Completed
Has Results
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: Insulin glargine;   Drug: Metformin
3 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
4 Active, not recruiting Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
Condition: Esophageal Carcinoma
Interventions: Drug: Tetrathiomolybdate (TM);   Procedure: Radiation;   Procedure: Surgery
5 Completed Relationship Between the Biological and Psychological Correlates of PTSD
Condition: Post-Traumatic Stress Disorder
Intervention: Behavioral: Prolonged Exposure Therapy
6 Completed The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: ethinyl estradiol and levonorgestrel; exenatide
7 Active, not recruiting Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder
Condition: Lymphoproliferative Disorder
Intervention: Biological: autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine
8 Completed Enhancing the Prospective Prediction of Psychosis
Conditions: Schizophrenia;   Psychotic Disorders
Intervention:
9 Completed Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
Conditions: Chromosomal Aberrations;   Cosmic Radiation
Intervention:
10 Completed Parkinson's Genes and Environment Study
Condition: Parkinson's Disease
Intervention:
11 Suspended Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vatalanib;   Drug: pemetrexed disodium;   Other: pharmacological study;   Procedure: ultrasound imaging
12 Terminated
Has Results
Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)
Condition: Hepatitis C, Chronic
Intervention: Drug: Combination of pegylated interferon alfa-2b (PEG) and ribavirin (RBV)
13 Recruiting Inflammatory Breast Cancer (IBC) Registry
Condition: Breast Cancer
Interventions: Other: Interview;   Procedure: Blood and Tissue Collection
14 Completed Preoperative Octreotide Treatment of Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide;   Procedure: Direct surgery for acromegaly
15 Completed Clinical Trial of Abstinence-Linked Money Management
Condition: Substance Abuse
Interventions: Behavioral: Advisor-Teller Money Manager;   Behavioral: FIT
16 Completed
Has Results
Cutivate Lotion HPA Axis Pediatric Study
Condition: Atopic Dermatitis
Intervention: Drug: Fluticasone propionate 0.05% lotion
17 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
18 Completed
Has Results
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BI 1744CL
19 Completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: letrozole;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
20 Completed
Has Results
Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant
Condition: Leukemia
Interventions: Drug: 5-azacitidine;   Procedure: Allogeneic Hematopoietic Cell Transplantation (HCT)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years